| Patient | Ernest Hemingway |
|---|---|
| Date of birth | 1970-07-21 |
| Identifiers | MRN HR-ET003-SYN; SSN (made up) 000-03-7419 |
| Document date | 2026-03-02 |
| Author | Walter Brandt-Ochoa, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing primary care: heavy drinking, low mood and forgetfulness a year after two plane crashes, with high blood pressure and abnormal liver and iron tests on the intake panel [S]
This fictional modern episode addresses the presenting concerns below. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
8 later historical claims are omitted because they describe events after the index age. See the teaching note.
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1918 | Wounded by a mortar shell near Fossalta di Piave while serving with an ambulance unit in Italy, with a long hospital stay | D (CLM-0002) |
| January 1954 | Two plane crashes in Uganda on consecutive days: concussion and skull fracture, ruptured right kidney, and liver and spleen injuries, with lasting pain | D (CLM-0004) |
| by 1954 | Heavy drinking for most of his adult life | D (CLM-0003) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Depression and diabetes; died by suicide in 1928 | D (CLM-0007) |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naltrexone 50 mg oral tablet, one tablet daily, to reduce heavy drinking | One tablet daily | Oral route | 2026-03-02 | active | S |
| Thiamine 100 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-02 to 2026-08-31 | completed | S |
| Sertraline 50 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-02 to 2026-04-13 | completed | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-02 to 2026-06-08 | completed | S |
Positive for the concerns in the history of present illness. Alert, courteous and guarded at first, then direct; speech normal in rate; smells of alcohol at a late-morning visit without signs of intoxication or withdrawal. Mood low; PHQ-9 16 with item 9 scored 1; Mood Disorder Questionnaire negative; no psychotic features; passive thoughts that he would be better off dead on several days, without intent or plan. MoCA 25 of 30: lost points on delayed recall and serial sevens; oriented; language and visuospatial items normal. No other systems reported as affected in this synthetic episode. [S]
Alert and engaged. Independent in all activities; back pain and stiffness since the crashes limit long walks; writing more slowly than before. [S]
Vital signs recorded on 2026-03-02; see the Vital Signs section. Mental status: Alert, courteous and guarded at first, then direct; speech normal in rate; smells of alcohol at a late-morning visit without signs of intoxication or withdrawal; Mood low; PHQ-9 16 with item 9 scored 1; Mood Disorder Questionnaire negative; no psychotic features; passive thoughts that he would be better off dead on several days, without intent or plan; MoCA 25 of 30: lost points on delayed recall and serial sevens; oriented; language and visuospatial items normal. The physical examination is limited to the findings relevant to this synthetic episode. [S]
Structured safety assessment: current ideation present, intent absent, plan absent, access to means reviewed: yes. Outpatient care with close follow-up. C-SSRS screen: wish to be dead on several days in the past month; no active thoughts of suicide, intent, plan, preparation or past attempt. Risk factors reviewed without detail: a father who died by suicide, other deaths by suicide in his family, heavy drinking, depression, repeated head injuries, chronic pain, and firearms at home. Lethal-means counseling about firearms was done respectfully, as a hunter's safety question rather than a judgment: he chose to have his guns held in the locked storage at his shooting club while his mood and drinking are treated, and to keep no ammunition at home. A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in his phone. Safety is reviewed at every visit. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-02 | Body height | 183 | cm | S |
| 2026-03-02 | Body weight | 98 | kg | S |
| 2026-03-02 | Body mass index (BMI) [Ratio] | 29.3 | kg/m2 | S |
| 2026-03-02 | Systolic blood pressure | 152 | mm[Hg] | S |
| 2026-03-02 | Diastolic blood pressure | 94 | mm[Hg] | S |
| 2026-03-02 | Heart rate | 88 | /min | S |
| 2026-03-02 | Respiratory rate | 16 | /min | S |
| 2026-03-02 | Body temperature | 36.8 | Cel | S |
| 2026-03-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-02 | Hemoglobin [Mass/volume] in Blood | 15.6 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 2026-03-02 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 102 | fL | 80-100 fL | High | S |
| 2026-03-02 | Platelets [#/volume] in Blood by Automated count | 208 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-03-02 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-02 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-02 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-03-02 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 91 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-02 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-02 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 70 | U/L | 10-40 U/L | High | S |
| 2026-03-02 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 78 | U/L | 7-55 U/L | High | S |
| 2026-03-02 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 196 | U/L | 8-61 U/L | High | S |
| 2026-03-02 | Bilirubin.total [Mass/volume] in Serum or Plasma | 1 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 2026-03-02 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-03-02 | Iron [Mass/volume] in Serum or Plasma | 214 | ug/dL | 65-175 ug/dL | High | S |
| 2026-03-02 | Iron saturation [Mass Fraction] in Serum or Plasma | 76 | % | 20-50% | High | S |
| 2026-03-02 | Ferritin [Mass/volume] in Serum or Plasma | 1460 | ng/mL | 24-336 ng/mL | High | S |
| 2026-03-02 | Hemoglobin A1c/Hemoglobin.total in Blood | 6.1 | % | 4-5.6% | High | S |
| 2026-03-02 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | <=199 mg/dL | High | S |
| 2026-03-02 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 118 | mg/dL | <=129 mg/dL | Normal | S |
| 2026-03-02 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-03-02 | Triglyceride [Mass/volume] in Serum or Plasma | 236 | mg/dL | <=149 mg/dL | High | S |
| 2026-03-02 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 2026-03-02 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 412 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-03-02 | Albumin/Creatinine [Mass Ratio] in Urine | 14 | mg/g | <=29 mg/g | Normal | S |
| 2026-03-02 | Total score [AUDIT] | 26 | {score} | S | ||
| 2026-03-02 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 16 | {score} | S | ||
| 2026-03-02 | Total score [MoCA] | 25 | {score} | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Alcohol use disorder, severe; heavy daily drinking for most of his adult life; synthetic modern episode linked to his documented heavy drinking | active | confirmed | F10.20 | S — Synthetic modern coding of DSM-5-TR severe alcohol use disorder (seven criteria); person-first language; not a claim about his real diagnosis. |
| Raised transferrin saturation and ferritin found on routine intake tests, cause not yet known (heavy drinking, liver disease or iron overload) | active | confirmed | R79.0 | S — Synthetic presenting finding; superseded when HFE testing gave the diagnosis. |
| Major depressive disorder, single episode, moderate; Mood Disorder Questionnaire negative and no history of mania or hypomania | active | confirmed | F32.1 | S — Synthetic modern diagnosis; not a claim about his real mood. The roster's bipolar disorder lead is disputed (CLM-0014) and is not used. |
| Essential hypertension, stage 2, with heavy drinking contributing | active | confirmed | I10 | S — Synthetic modern diagnosis confirmed by home readings. |
| Post-concussion symptoms (headaches, slowed thinking and forgetfulness) after repeated head injuries, most recently a concussion with a skull fracture a year ago; chronic traumatic encephalopathy is not diagnosed | active | confirmed | F07.81 | S — Synthetic modern diagnosis anchored to his documented head injuries; alcohol and depression also affect the symptoms. |
| Prediabetes (HbA1c 6.1%) | active | confirmed | R73.03 | S — Synthetic finding on diabetes screening; iron overload and alcohol both raise the risk of diabetes. |